

( (S (NP-SBJ (NP (NP Lyphomed Inc.)
                 ,
                 (NP (NP Rosemont)
		     ,
		     (NP Ill.))
                 ,)
             and
             (NP (NP Medco Research Inc.)
                 ,
                 (NP Los Angeles)
                 ,))
     (VP said
         (SBAR 0
               (S (NP-SBJ the Food and Drug Administration)
                  (VP granted
                      (NP (NP full marketing approval)
                          (PP for
                              (NP (NP a new drug)
                                  (PP for
                                      (NP (NP the treatment)
                                          (PP of
                                              (NP (NP a condition)
                                                  (SBAR (WHPP-1 in
								(WHNP which))
                                                        (S (NP-SBJ the heart)
                                                           (VP beats
							       (NP (NP (QP between 150 
									   and 200) 
								       beats)
								   (NP-ADV a minute))
							       (PP-LOC *T*-1)))))))))))))))
     .))
( (S (NP-SBJ (NP The condition)
             ,
             (VP known
                 (NP *)
                 (PP-CLR as
			 (NP paroxysmal supraventricular tachycardia)))
             ,)
     (VP leads
         (PP-CLR to
		 (NP dizziness
		     and
		     fainting)))
     .))
( (S (NP-SBJ The
             typical healthy
             heart)
     (VP beats
         (NP (NP 70 times)
             (NP-ADV a minute)))
     .))
( (S (NP-SBJ (NP The drug)
             ,
             (VP called
                 (S (NP-SBJ *) 
		    (NP-PRD adenocard)))
             ,)
     (VP returns
         (NP the heart)
         (PP-CLR to
		 (NP a normal rhythm))
	 (PP-TMP within
		 (NP seconds))
	 ,
	 (PP according
	     (PP to
		 (NP Lyphomed))))
     .))
( (S (NP-SBJ Medco Research)
     (VP (VP developed
             (NP the drug))
         and
         (VP licensed
             (NP it)
             (PP-CLR to
		     (NP Lyphomed))
             (PP-CLR for
		     (NP (NP sale)
			 (PP-LOC in
				 (NP (NP the U.S.) and (NP Canada)))))))
     .))
